News for Kiromic Biopharma Stock (KRBP)

ROSEN, Leading Investor Counsel, Encourages Kiromic BioPharma, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - KRBP

Newsfile Corp • 09/03/22

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 09/02/22

CLASS ACTION: Kessler Topaz Meltzer & Check, LLP Reminds Kiromic BioPharma, Inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm

Newsfile Corp • 09/01/22

ROSEN, Top Ranked Investor Counsel, Encourages Kiromic BioPharma, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - KRBP

Newsfile Corp • 09/01/22

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 08/31/22

INVESTOR NOTIFICATION: Kessler Topaz Meltzer & Check, LLP Announces Lead Plaintiff Deadline on October 4, 2022 in Securities Fraud Class Action Lawsuit Filed against Kiromic BioPharma, Inc.

PRNewsWire • 08/29/22

ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Kiromic BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KRBP

Newsfile Corp • 08/28/22

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Kiromic BioPharma (KRBP) Investors with Significant Losses to Contact Firm's Attorneys, Deadline Approaching in Securities Class Action

Newsfile Corp • 08/26/22

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Kiromic BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KRBP

Newsfile Corp • 08/25/22

ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Kiromic BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KRBP

PRNewsWire • 08/24/22

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Kiromic BioPharma (KRBP) Investors with Significant Losses to Contact Firm's Attorneys, Securities Class Action Filed

Newsfile Corp • 08/24/22

ROSEN, National Trial Lawyers, Encourages Kiromic BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KRBP

Newsfile Corp • 08/22/22

Kiromic Biopharma, Inc. Shareholder News: Robbins LLP is Investigating Kiromic Biopharma, Inc. (KRBP) on Behalf of Shareholders

Business Wire • 08/22/22

CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Reminds Kiromic BioPharma, Inc. Shareholders of Securities Fraud Class Action Lawsuit

Newsfile Corp • 08/22/22

KRBP CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Kiromic BioPharma, Inc. Shareholders of Securities Fraud Class Action Lawsuit

PRNewsWire • 08/20/22

ROSEN, A LEADING LAW FIRM, Encourages Kiromic BioPharma, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - KRBP

Newsfile Corp • 08/19/22

Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed against Kiromic BioPharma, Inc. (KRBP) and Encourages Investors with Significant Losses to Contact the Firm

Business Wire • 08/19/22

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Investors in Kiromic BioPharma, Inc. (KRBP) with Significant Losses to Contact Firm's Attorneys, Securities Class Action Pending

Newsfile Corp • 08/19/22

Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Kiromic BioPharma, Inc. (KRBP) Investors of Class Action and to Actively Participate

Business Wire • 08/18/22

KRBP ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 4, 2022 in the Class Action Filed on Behalf of Kiromic BioPharma, Inc. Limited Shareholders

Newsfile Corp • 08/18/22

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Investors in Kiromic BioPharma, Inc. (KRBP) with Significant Losses to Contact Firm's Attorneys, Deadline Established in Securities Class Action

Newsfile Corp • 08/17/22

KRBP INVESTOR NEWS: ROSEN, A LEADING NATIONAL FIRM, Encourages Kiromic BioPharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - KRBP

PRNewsWire • 08/15/22

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Investors in Kiromic BioPharma, Inc. (KRBP) with Significant Losses to Contact Firm's Attorneys, Securities Class Action Filed

PRNewsWire • 08/15/22

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Kiromic BioPharma, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - KRBP

Newsfile Corp • 08/13/22

Kiromic Biopharma, Inc. Shareholder Update: Robbins LLP Reminds Investors of Class Action Against Kiromic Biopharma, Inc. (KRBP)

Business Wire • 08/12/22